[ACRX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
01-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -2.79%
YoY- -324.94%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 2,659 3,109 6,435 3,366 4,531 3,025 1,730 33.21%
PBT -13,057 -15,551 -9,682 -11,438 -11,092 -10,979 -10,558 15.22%
Tax 2 -2,704 68 -36 -2,083 2 -12 -
NP -13,059 -15,551 -9,682 -11,402 -11,092 -10,981 -10,546 15.32%
Tax Rate - - - - - - - -
Total Cost 15,718 18,660 16,117 14,768 15,623 14,006 12,276 17.93%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -491.12 -500.19 -150.46 -338.74 -244.80 -363.01 -609.60 -13.42%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -5.76 -6.86 -4.27 -5.03 -4.90 -4.85 -4.66 15.18%
EPS Diluted -5.76 -6.86 -4.27 -5.03 -4.90 -4.85 -4.66 15.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.